• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征(PCOS)患者2型糖尿病(T2DM)和空腹血糖受损风险:8年随访结果

Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up.

作者信息

Boudreaux Monique Y, Talbott Evelyn O, Kip Kevin E, Brooks Maria M, Witchel Selma F

出版信息

Curr Diab Rep. 2006 Feb;6(1):77-83. doi: 10.1007/s11892-006-0056-1.

DOI:10.1007/s11892-006-0056-1
PMID:16522285
Abstract

Women with polycystic ovary syndrome (PCOS) often develop type 2 diabetes mellitus (T2DM). To determine the magnitude of risk of developing T2DM among women with PCOS, development of T2DM was prospectively assessed among women who had T2DM (n = 97) and controls (n = 95) using Kaplan-Meier survival analysis and Cox proportional hazards modeling. The women with T2DM had higher baseline weight (body mass index, P < 0.01) and lower insulin sensitivity (homeostasis assessment model of insulin resistance, P < 0.01). The 8-year incidence rate among cases and controls was 13.4% and 5.8%, respectively (relative risk = 2.3). Obese cases had a fivefold risk of T2DM developing (P < 0.01) compared with age-adjusted obese controls, indicating significant interaction between PCOS and obesity to effect T2DM risk.

摘要

多囊卵巢综合征(PCOS)女性常患2型糖尿病(T2DM)。为确定PCOS女性患T2DM的风险程度,采用Kaplan-Meier生存分析和Cox比例风险模型,对患有T2DM的女性(n = 97)和对照组女性(n = 95)进行前瞻性评估,以了解T2DM的发病情况。患有T2DM的女性基线体重更高(体重指数,P < 0.01),胰岛素敏感性更低(胰岛素抵抗稳态评估模型,P < 0.01)。病例组和对照组的8年发病率分别为13.4%和5.8%(相对风险 = 2.3)。与年龄调整后的肥胖对照组相比,肥胖病例患T2DM的风险高出五倍(P < 0.01),表明PCOS与肥胖之间存在显著的相互作用,从而影响T2DM风险。

相似文献

1
Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up.多囊卵巢综合征(PCOS)患者2型糖尿病(T2DM)和空腹血糖受损风险:8年随访结果
Curr Diab Rep. 2006 Feb;6(1):77-83. doi: 10.1007/s11892-006-0056-1.
2
An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.一项关于二甲双胍联合饮食治疗多囊卵巢综合征女性胰岛素抵抗降低及预防2型糖尿病发生的观察性研究。
Metabolism. 2008 Jul;57(7):954-60. doi: 10.1016/j.metabol.2008.02.011.
3
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.多囊卵巢综合征中2型糖尿病和糖耐量受损的患病率及风险预测因素:一项对254名患病女性的前瞻性对照研究
J Clin Endocrinol Metab. 1999 Jan;84(1):165-9. doi: 10.1210/jcem.84.1.5393.
4
Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?多囊卵巢综合征中的 2 型糖尿病和心血管疾病:风险有哪些,能否降低?
Diabet Med. 2010 May;27(5):498-515. doi: 10.1111/j.1464-5491.2010.02994.x.
5
Prevalence of type 2 diabetes mellitus compared between lean and overweight/obese patients with polycystic ovarian syndrome: a 5-year follow-up study.多囊卵巢综合征患者中瘦体重和超重/肥胖患者 2 型糖尿病患病率比较:一项 5 年随访研究。
Arch Gynecol Obstet. 2020 Mar;301(3):809-816. doi: 10.1007/s00404-019-05423-2. Epub 2020 Jan 11.
6
Risk of type 2 diabetes mellitus in polycystic ovary syndrome is associated with obesity: a meta-analysis of observational studies.多囊卵巢综合征患者发生 2 型糖尿病的风险与肥胖有关:一项观察性研究的荟萃分析。
Endocrine. 2021 Nov;74(2):245-253. doi: 10.1007/s12020-021-02801-2. Epub 2021 Jun 26.
7
Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study.多囊卵巢综合征非肥胖女性 2 型糖尿病发病风险增加:国家健康保险服务-国家样本队列研究。
Fertil Steril. 2021 Jun;115(6):1569-1575. doi: 10.1016/j.fertnstert.2020.12.018. Epub 2021 Jan 26.
8
High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).印度患有多囊卵巢综合征(PCOS)的青春期女性的高敏C反应蛋白(hs-CRP)水平及其与多囊卵巢综合征各组分的关系。
Gynecol Endocrinol. 2014 Nov;30(11):781-4. doi: 10.3109/09513590.2014.924099. Epub 2014 Aug 19.
9
Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.中国大规模多囊卵巢综合征女性临床特征分析
Neuro Endocrinol Lett. 2007 Dec;28(6):807-10.
10
Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study.多囊卵巢综合征年轻女性不良结局的评估:一项回顾性、观察性研究。
J Clin Endocrinol Metab. 2012 Sep;97(9):3251-60. doi: 10.1210/jc.2012-1690. Epub 2012 Jul 5.

引用本文的文献

1
Abnormally Increased Prolactin Levels in Women with Polycystic Ovarian Syndrome Are Associated with Risk of Obesity, Insulin Resistance and Prediabetes.多囊卵巢综合征女性催乳素水平异常升高与肥胖、胰岛素抵抗和糖尿病前期风险相关。
Int J Mol Sci. 2025 Apr 29;26(9):4239. doi: 10.3390/ijms26094239.
2
Irregular Cycles, Ovulatory Disorders, and Cardiometabolic Conditions in a US-Based Digital Cohort.美国数字队列中的月经周期不规律、排卵障碍和心脏代谢疾病
JAMA Netw Open. 2024 May 1;7(5):e249657. doi: 10.1001/jamanetworkopen.2024.9657.
3
Sinapic acid modulates oxidative stress and metabolic disturbances to attenuate ovarian fibrosis in letrozole-induced polycystic ovary syndrome SD rats.

本文引用的文献

1
Managing type 2 diabetes mellitus in patients with obesity.肥胖患者2型糖尿病的管理
Treat Endocrinol. 2004;3(4):223-32. doi: 10.2165/00024677-200403040-00004.
2
Polycystic ovary syndrome.多囊卵巢综合征
N Engl J Med. 2005 Mar 24;352(12):1223-36. doi: 10.1056/NEJMra041536.
3
Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome.多囊卵巢综合征女性卵泡膜细胞中细胞色素P450 17α-羟化酶信使核糖核酸稳定性的失调
阿魏酸调节氧化应激和代谢紊乱以减轻来曲唑诱导的多囊卵巢综合征SD大鼠的卵巢纤维化。
Food Sci Nutr. 2024 Jan 24;12(4):2917-2931. doi: 10.1002/fsn3.3973. eCollection 2024 Apr.
4
Influence of Phenotypes on the Metabolic Syndrome of Women with Polycystic Ovary Syndrome over a Six-Year Follow-Up in Brazil.巴西六年随访期间多囊卵巢综合征女性的表型对代谢综合征的影响。
Biomedicines. 2023 Dec 9;11(12):3262. doi: 10.3390/biomedicines11123262.
5
Melatonin as a promising therapeutic intervention for restoring ovarian function in letrozole-induced polycystic ovary syndrome rats.褪黑素作为一种有前景的治疗干预手段,用于恢复来曲唑诱导的多囊卵巢综合征大鼠的卵巢功能。
Heliyon. 2023 Oct 27;9(11):e21237. doi: 10.1016/j.heliyon.2023.e21237. eCollection 2023 Nov.
6
A systematic review of models of care for polycystic ovary syndrome highlights the gap in the literature, especially in developing countries.一项针对多囊卵巢综合征护理模式的系统评价突出了文献中的空白,特别是在发展中国家。
Front Endocrinol (Lausanne). 2023 Jul 19;14:1217468. doi: 10.3389/fendo.2023.1217468. eCollection 2023.
7
Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome.多囊卵巢综合征年轻女性2型糖尿病风险评估
Diagnostics (Basel). 2023 Jun 14;13(12):2067. doi: 10.3390/diagnostics13122067.
8
Potentials of curcumin against polycystic ovary syndrome: Pharmacological insights and therapeutic promises.姜黄素治疗多囊卵巢综合征的潜力:药理学见解与治疗前景
Heliyon. 2023 Jun 2;9(6):e16957. doi: 10.1016/j.heliyon.2023.e16957. eCollection 2023 Jun.
9
Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome.多囊卵巢综合征女性骨骼肌功能障碍的特征分析
Ther Adv Endocrinol Metab. 2022 Jul 18;13:20420188221113140. doi: 10.1177/20420188221113140. eCollection 2022.
10
Effects of Kelulut Honey on Oestrus Cycle Regulation and Histomorphological Changes in Letrozole-Induced Polycystic Ovary Syndrome Rats: A Preliminary Study.吉罗鲁特蜂蜜对来曲唑诱导的多囊卵巢综合征大鼠发情周期调节及组织形态学变化的影响:一项初步研究
Life (Basel). 2022 Jun 14;12(6):890. doi: 10.3390/life12060890.
J Clin Endocrinol Metab. 2005 Mar;90(3):1720-7. doi: 10.1210/jc.2004-1860. Epub 2004 Dec 14.
4
The prevalence and features of the polycystic ovary syndrome in an unselected population.未选择人群中多囊卵巢综合征的患病率及特征
J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9. doi: 10.1210/jc.2003-032046.
5
Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.多囊卵巢综合征女性患心血管疾病的风险是否增加?证据综述。
Minerva Ginecol. 2004 Feb;56(1):27-39.
6
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.2003年修订的关于多囊卵巢综合征诊断标准及长期健康风险的共识。
Fertil Steril. 2004 Jan;81(1):19-25. doi: 10.1016/j.fertnstert.2003.10.004.
7
Increased cytochrome P450 17alpha-hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1.多囊卵巢综合征患者分离出的卵泡膜细胞中,细胞色素P450 17α-羟化酶启动子功能增强涉及核因子-1。
Mol Endocrinol. 2004 Mar;18(3):588-605. doi: 10.1210/me.2003-0090. Epub 2003 Dec 18.
8
Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.胰岛素抵抗、多囊卵巢综合征与2型糖尿病
Fertil Steril. 2002 Jun;77(6):1095-105. doi: 10.1016/s0015-0282(02)03111-4.
9
Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity.多囊卵巢综合征女性患者姐妹中的胰岛素抵抗:与高雄激素血症相关而非月经不规律。
J Clin Endocrinol Metab. 2002 May;87(5):2128-33. doi: 10.1210/jcem.87.5.8513.
10
The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome.多囊卵巢综合征患者来源的卵泡膜细胞中睾酮生成增加的生化基础。
J Clin Endocrinol Metab. 2001 Dec;86(12):5925-33. doi: 10.1210/jcem.86.12.8088.